Further investigation of how ALS-linked TBK1 variants alter TBK1 structure, phosphorylation, and dimerization will help unravel the disease pathogenesis and identify novel therapeutic targets. This evidence concerns the gene TBK1 and amyotrophic lateral sclerosis.